tiprankstipranks
Takeda Pharmaceutical Co Ltd (JP:4502)
:4502
Japanese Market
4502
Takeda Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4502 full AI Analyst Report?

Takeda Pharmaceutical Co (4502) Ratios

8 Followers

Takeda Pharmaceutical Co Ratios

JP:4502's free cash flow for Q4 2025 was ¥0.49. For the 2025 fiscal year, JP:4502's free cash flow was decreased by ¥ and operating cash flow was ¥0.04. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.27 1.27 1.01 1.11 0.97
Quick Ratio
 0.70 0.70 0.52 0.58 0.57
Cash Ratio
 0.24 0.24 0.09 0.09 0.09
Solvency Ratio
 0.12 0.12 0.12 0.11 0.13
Operating Cash Flow Ratio
 0.40 0.39 0.38 0.28 0.35
Short-Term Operating Cash Flow Coverage
 1.90 1.83 1.57 1.48 2.20
Net Current Asset Value
¥ -4.59T¥ -4.59T¥ -4.79T¥ -5.28T¥ -5.21T
Leverage Ratios
Debt-to-Assets Ratio
 0.32 0.32 0.36 0.36 0.35
Debt-to-Equity Ratio
 0.63 0.63 0.73 0.75 0.77
Debt-to-Capital Ratio
 0.39 0.39 0.42 0.43 0.43
Long-Term Debt-to-Capital Ratio
 0.36 0.36 0.36 0.38 0.39
Financial Leverage Ratio
 1.99 1.99 2.05 2.08 2.20
Debt Service Coverage Ratio
 1.55 1.37 1.33 1.74 2.10
Interest Coverage Ratio
 1.33 1.51 3.36 3.46 4.83
Debt to Market Cap
 0.60 0.55 0.66 0.75 0.66
Interest Debt Per Share
 3.35K 3.33K 3.34K 3.59K 3.22K
Net Debt to EBITDA
 3.03 3.40 4.31 5.67 3.91
Profitability Margins
Gross Profit Margin
58.76%51.06%53.59%54.53%57.07%
EBIT Margin
14.95%11.99%7.99%4.69%12.91%
EBITDA Margin
31.41%28.00%24.61%21.76%29.41%
Operating Profit Margin
10.54%11.99%13.70%12.46%16.34%
Pretax Profit Margin
5.77%5.77%3.82%1.24%9.31%
Net Profit Margin
4.26%4.26%2.36%3.38%7.87%
Continuous Operations Profit Margin
4.26%4.26%2.36%3.38%7.87%
Net Income Per EBT
73.70%73.70%61.64%272.90%84.52%
EBT Per EBIT
54.77%48.14%27.90%9.93%56.98%
Return on Assets (ROA)
1.24%1.24%0.76%0.95%2.27%
Return on Equity (ROE)
2.61%2.47%1.56%1.98%4.99%
Return on Capital Employed (ROCE)
3.65%4.15%5.34%4.15%5.74%
Return on Invested Capital (ROIC)
2.59%2.95%3.14%4.02%4.69%
Return on Tangible Assets
3.08%3.08%2.04%2.66%6.47%
Earnings Yield
2.37%2.15%1.55%2.21%4.70%
Efficiency Ratios
Receivables Turnover
 5.14 5.14 6.32 6.11 5.91
Payables Turnover
 3.78 4.49 6.89 6.06 5.62
Inventory Turnover
 1.33 1.58 1.75 1.60 1.75
Fixed Asset Turnover
 2.12 2.12 2.33 2.14 2.38
Asset Turnover
 0.29 0.29 0.32 0.28 0.29
Working Capital Turnover Ratio
 7.72 13.34 35.22 52.80 22.13
Cash Conversion Cycle
 248.82 220.84 213.80 227.25 205.11
Days of Sales Outstanding
 70.99 70.99 57.78 59.72 61.78
Days of Inventory Outstanding
 274.35 231.17 208.96 227.76 208.23
Days of Payables Outstanding
 96.52 81.33 52.95 60.23 64.90
Operating Cycle
 345.34 302.16 266.74 287.48 270.01
Cash Flow Ratios
Operating Cash Flow Per Share
 621.48 595.98 609.61 409.29 565.29
Free Cash Flow Per Share
 500.69 484.24 482.43 297.17 474.65
CapEx Per Share
 120.78 111.74 127.18 112.13 90.64
Free Cash Flow to Operating Cash Flow
 0.81 0.81 0.79 0.73 0.84
Dividend Paid and CapEx Coverage Ratio
 1.94 1.92 1.91 1.38 2.09
Capital Expenditure Coverage Ratio
 5.15 5.33 4.79 3.65 6.24
Operating Cash Flow Coverage Ratio
 0.20 0.19 0.19 0.12 0.18
Operating Cash Flow to Sales Ratio
 0.22 0.21 0.21 0.15 0.22
Free Cash Flow Yield
9.58%8.55%10.93%7.15%10.91%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 42.29 46.52 64.56 45.16 21.29
Price-to-Sales (P/S) Ratio
 1.82 1.98 1.52 1.53 1.68
Price-to-Book (P/B) Ratio
 1.04 1.15 1.00 0.89 1.06
Price-to-Free Cash Flow (P/FCF) Ratio
 10.48 11.70 9.15 14.00 9.16
Price-to-Operating Cash Flow Ratio
 8.35 9.50 7.24 10.16 7.70
Price-to-Earnings Growth (PEG) Ratio
 0.54 0.60 -2.51 -0.82 0.55
Price-to-Fair Value
 1.04 1.15 1.00 0.89 1.06
Enterprise Value Multiple
 8.82 10.47 10.49 12.68 9.61
Enterprise Value
 12.45T 13.21T 11.82T 11.76T 11.38T
EV to EBITDA
 8.80 10.47 10.49 12.68 9.61
EV to Sales
 2.76 2.93 2.58 2.76 2.83
EV to Free Cash Flow
 15.91 17.32 15.52 25.31 15.45
EV to Operating Cash Flow
 12.82 14.07 12.28 18.37 12.98
Tangible Book Value Per Share
 -930.23 -922.86 -1.28K -1.54K -1.74K
Shareholders’ Equity Per Share
 4.97K 4.94K 4.39K 4.65K 4.09K
Tax and Other Ratios
Effective Tax Rate
 0.26 0.26 0.38 -1.73 0.15
Revenue Per Share
 2.88K 2.86K 2.90K 2.73K 2.60K
Net Income Per Share
 122.72 121.75 68.36 92.09 204.29
Tax Burden
 0.74 0.74 0.62 2.73 0.85
Interest Burden
 0.39 0.48 0.48 0.26 0.72
Research & Development to Revenue
 0.15 0.15 0.16 0.17 0.16
SG&A to Revenue
 0.24 0.24 0.24 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 0.00 0.00 0.00 0.00
Income Quality
 5.06 4.90 8.92 4.44 2.77
Currency in JPY